333 related articles for article (PubMed ID: 19707183)
1. Cardiovascular pharmacogenomics and individualized drug therapy.
Pereira NL; Weinshilboum RM
Nat Rev Cardiol; 2009 Oct; 6(10):632-8. PubMed ID: 19707183
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics in cardiovascular disease: the challenge of moving from promise to realization: concepts discussed at the Canadian Network and Centre for Trials Internationally Network Conference (CANNeCTIN), June 2009.
Joseph PG; Pare G; Ross S; Roberts R; Anand SS
Clin Cardiol; 2014 Jan; 37(1):48-56. PubMed ID: 24105892
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S
Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy.
Mango R; Vecchione L; Raso B; Borgiani P; Brunetti E; Mehta JL; Lauro R; Romeo F; Novelli G
Expert Opin Pharmacother; 2005 Dec; 6(15):2565-76. PubMed ID: 16316297
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular pharmacogenomics.
Roden DM; Johnson JA; Kimmel SE; Krauss RM; Medina MW; Shuldiner A; Wilke RA
Circ Res; 2011 Sep; 109(7):807-20. PubMed ID: 21921273
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics: the genetics of variable drug responses.
Roden DM; Wilke RA; Kroemer HK; Stein CM
Circulation; 2011 Apr; 123(15):1661-70. PubMed ID: 21502584
[No Abstract] [Full Text] [Related]
7. Cardiovascular drugs and the genetic response.
Dandona S
Methodist Debakey Cardiovasc J; 2014; 10(1):13-7. PubMed ID: 24932357
[TBL] [Abstract][Full Text] [Related]
8. Genomics and the prospects of existing and emerging therapeutics for cardiovascular diseases.
Zaiou M; Benachour H; Marteau JB; Visvikis-Siest S; Siest G
Curr Pharm Des; 2009; 15(27):3193-206. PubMed ID: 19754391
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics, pharmacogenomics, and cardiovascular therapeutics: the way forward.
Terra SG; Johnson JA
Am J Cardiovasc Drugs; 2002; 2(5):287-96. PubMed ID: 14727958
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of cardiovascular drugs.
Saleh A; Al-Abcha A; Pereira N
Curr Opin Cardiol; 2023 May; 38(3):207-214. PubMed ID: 37016993
[TBL] [Abstract][Full Text] [Related]
11. Recent developments and future directions for the use of pharmacogenomics in cardiovascular disease treatments.
Berinstein E; Levy A
Expert Opin Drug Metab Toxicol; 2017 Sep; 13(9):973-983. PubMed ID: 28792790
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers.
Siest G; Marteau JB; Maumus S; Berrahmoune H; Jeannesson E; Samara A; Batt AM; Visvikis-Siest S
Eur J Pharmacol; 2005 Dec; 527(1-3):1-22. PubMed ID: 16316654
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics in Cardiovascular Medicine.
Weeke PE
Adv Pharmacol; 2018; 83():333-360. PubMed ID: 29801582
[TBL] [Abstract][Full Text] [Related]
14. Opportunities and Challenges in Cardiovascular Pharmacogenomics: From Discovery to Implementation.
Roden DM; Van Driest SL; Wells QS; Mosley JD; Denny JC; Peterson JF
Circ Res; 2018 Apr; 122(9):1176-1190. PubMed ID: 29700066
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular pharmacogenomics: the future of cardiovascular therapeutics?
Roden DM
Can J Cardiol; 2013 Jan; 29(1):58-66. PubMed ID: 23200096
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics for the Clinical Practitioner.
Sleder AT; Kalus J; Lanfear DE
J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):20-6. PubMed ID: 26054891
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics and cardiology: improving treatment with existing drugs.
Sorrentino MJ; O'Donnell PH
Pharmacogenomics; 2015; 16(11):1223-6. PubMed ID: 26369612
[No Abstract] [Full Text] [Related]
18. From SNPs to functional studies in cardiovascular pharmacogenomics.
Cresci S
Methods Mol Biol; 2008; 448():379-93. PubMed ID: 18370238
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular pharmacogenomics; state of current knowledge and implementation in practice.
Shahabi P; Dubé MP
Int J Cardiol; 2015 Apr; 184():772-795. PubMed ID: 25838112
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic relevance of pharmacogenetic factors in cardiovascular medicine.
Nakagawa K; Ishizaki T
Pharmacol Ther; 2000 Apr; 86(1):1-28. PubMed ID: 10760544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
